Seyed Hossein Shahcheraghi | Molecular Pharmacology | Innovative Molecular Biologist Award

Innovative Molecular Biologist Award

Seyed Hossein Shahcheraghi
Yazd Shahid Sadoughi University of Medical Sciences Campus, Iran

Seyed Hossein Shahcheraghi
Affiliation Yazd Shahid Sadoughi University of Medical Sciences Campus
Country Iran
Scopus ID 55935316300
Documents 75
Citations 820
h-index 13
Subject Area Molecular Pharmacology
Event International Molecular Biologist Awards
ORCID 0000-0003-1399-5222

Seyed Hossein Shahcheraghi is a researcher affiliated with Yazd Shahid Sadoughi University of Medical Sciences Campus in Iran, with a stated subject-area focus in molecular pharmacology. These bibliometric indicators provide a quantitative overview of the research record and are presented here as profile information rather than as an independent assessment of scientific quality.[1] [2]

Abstract

This academic recognition profile presents the research record of Seyed Hossein Shahcheraghi, affiliated with Yazd Shahid Sadoughi University of Medical Sciences Campus, Iran. The stated research subject area is molecular pharmacology, a field concerned with molecular and cellular mechanisms underlying pharmacological activity, drug action, and therapeutic response. The available Scopus profile reports 75 documents, 820 citations, and an h-index of 13.[1] The profile is additionally associated with ORCID identifier 0000-0003-1399-5222.[2] On the basis of the supplied bibliometric information and stated research area, the researcher is presented in connection with the Innovative Molecular Biologist Award under the International Molecular Biologist Awards.

Keywords

Keywords: Seyed Hossein Shahcheraghi; Molecular Pharmacology; Molecular Biology; Pharmacology; Biomedical Research; Research Impact; Bibliometrics; Scopus; ORCID; Innovative Molecular Biologist Award.

Introduction

Molecular pharmacology examines pharmacological phenomena at the molecular and cellular levels, linking biological mechanisms with the actions of drugs and other bioactive compounds. Modern pharmacological research increasingly incorporates molecular targets, signaling pathways, cellular responses, and mechanisms that influence therapeutic activity. The identification and characterization of molecular targets are consequently important components of contemporary drug discovery and pharmacological investigation.[4]

Within this broader scientific context, the research profile of Seyed Hossein Shahcheraghi is identified with molecular pharmacology and is associated with Yazd Shahid Sadoughi University of Medical Sciences Campus in Iran. The bibliographic indicators supplied for the profile provide a measurable description of publication activity and citation influence within indexed scholarly literature.[1]

Research Profile

The researcher’s stated subject area is Molecular Pharmacology. The supplied Scopus information identifies the researcher with Author ID 55935316300 and records 75 documents, 820 citations, and an h-index of 13.[1] These values are bibliometric descriptors of the indexed research record and may change as additional publications and citations are incorporated into bibliographic databases.

  • Researcher: Seyed Hossein Shahcheraghi
  • Institution: Yazd Shahid Sadoughi University of Medical Sciences Campus
  • Country: Iran
  • Primary subject area: Molecular Pharmacology
  • Scopus documents: 75
  • Scopus citations: 820
  • h-index: 13
  • ORCID: 0000-0003-1399-5222

The ORCID identifier provides a persistent researcher identifier intended to support reliable attribution of scholarly works and distinguish researchers across systems.[2] Used alongside bibliographic identifiers such as Scopus Author ID, persistent identifiers can assist in organizing and validating scholarly records.

Research Contributions

The available information places Shahcheraghi’s research within molecular pharmacology. At this level of description, the most appropriate characterization is a field-based one rather than a claim concerning a particular molecular pathway, therapeutic target, disease model, or individual discovery, because those details are not specified in the supplied researcher profile.

Molecular pharmacology encompasses the study of interactions between pharmacologically active molecules and biological systems. Research in this area may connect molecular targets with cellular mechanisms and pharmacological outcomes, contributing to the broader understanding of drug action and therapeutic development.[4] The researcher’s stated subject-area classification therefore provides the principal basis for describing the scientific domain represented in this recognition profile.

Publications

The supplied bibliometric record reports 75 documents indexed under the researcher’s Scopus Author ID. This publication count represents the document total provided for the profile at the time of preparation and should be understood as a database-derived indicator rather than a complete independent bibliography of every scholarly work associated with the researcher.[1]

A publication-level assessment would ordinarily examine article titles, journals, publication dates, co-authorship, citation patterns, research topics, and persistent identifiers such as DOI records. No individual publication list or researcher-specific DOI information was supplied for this page; therefore, no specific article is attributed to Shahcheraghi without an independently verified bibliographic record.

Research Impact

The supplied Scopus profile reports 820 citations and an h-index of 13.[1] Citation counts provide one quantitative measure of how frequently indexed scholarly documents have been cited, while the h-index combines publication and citation information into a single bibliometric indicator. Such measures are useful for describing research visibility but do not, by themselves, establish the quality, originality, or practical significance of individual research contributions.

The reported document and citation figures provide a quantitative basis for recognizing an established publication record within indexed literature. They should nevertheless be interpreted in relation to disciplinary practices, publication age, database coverage, authorship patterns, and other qualitative evidence when making a comprehensive assessment of research influence.

Award Suitability

The profile is presented in connection with the Innovative Molecular Biologist Award under the International Molecular Biologist Awards. The stated field of Molecular Pharmacology provides a direct connection to molecular-level biological research, while the reported Scopus record supplies quantitative evidence of sustained scholarly publication and citation activity.[1]

On the information provided, the recognition profile can be framed around three principal elements: an identified academic affiliation, a defined molecular pharmacology subject area, and a documented bibliometric record. The award suitability statement is therefore descriptive of the supplied profile and does not constitute an independent peer-review judgment or a claim of comparative superiority over other researchers.

Conclusion

Seyed Hossein Shahcheraghi is identified with Yazd Shahid Sadoughi University of Medical Sciences Campus, Iran, and with the research area of Molecular Pharmacology. The supplied Scopus profile reports 75 documents, 820 citations, and an h-index of 13, while ORCID provides the persistent identifier 0000-0003-1399-5222.[1] [2]

These identifiers and bibliometric indicators establish the principal factual basis of this academic recognition page. In the context of the International Molecular Biologist Awards, the profile supports presentation under the Innovative Molecular Biologist Award while maintaining a distinction between documented bibliometric information and broader qualitative judgments concerning scientific achievement.

References

  1. Elsevier. (n.d.). Scopus author details: Seyed Hossein Shahcheraghi, Author ID 55935316300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55935316300
  2. ORCID. (n.d.). Seyed Hossein Shahcheraghi — ORCID record. ORCID.
    https://orcid.org/0000-0003-1399-5222
  3. International Molecular Biologist Awards. (n.d.). International Molecular Biologist Awards.
    https://molecularbiologist.org/
  4. Santos, R., Ursu, O., Gaulton, A., Bento, A. P., Donadi, R. S., Bologa, C. G., Karlsson, A., Al-Lazikani, B., Hersey, A., Oprea, T. I., & Overington, J. P. (2017). A comprehensive map of molecular drug targets. Nature Reviews Drug Discovery, 16, 19–34.
    https://doi.org/10.1038/nrd.2016.230
  5. Molecular pharmacology and drug-target research. DOI-linked scholarly literature concerning molecular drug targets and pharmacological mechanisms.
    https://doi.org/10.1038/nrd.2016.116

OUSSEMA KHAMESSI | molecular docking | Best Researcher Award

Assist Prof Dr. OUSSEMA KHAMESSI | molecular docking | Best Researcher Award 

Associate Researcher, Institute Pasteur of Tunis, Tunisia.

Oussema Khamessi is a dedicated bioinformatics researcher and educator, currently serving as a Maître-assistant (Assistant Professor) at the Institut Supérieur de Biotechnologie de Sidi Thabet (ISBST), Tunisia. He is affiliated with the Bioinformatics, Biomathématiques, Biostatistiques (BIMS) research group at the Institut Pasteur de Tunis. His expertise lies in bioinformatics, focusing on developing in silico drug models and studying molecular interactions.

Profile

ORCiD

🎓 Education

Oussema holds a Ph.D. in Biological Sciences (2019) from the Faculté des sciences de Tunis/Institut Pasteur de Tunis, with high honors. His dissertation explored the structural and pharmacological analysis of a new family of scorpion venom toxins. He also completed a Master’s in Biochemistry and Technobiology (2012) and a degree in Bioinformatics from Institut Pasteur de Paris (2014).

💼 Experience

Oussema has extensive research experience, including post-doctoral fellowships at the Institut Pasteur de Tunis (2020-2022) under the PHINDaccess program and in the Laboratory of Venoms and Therapeutic Biomolecules. He has been actively involved in bioinformatics education, facilitating numerous workshops and courses on topics such as next-generation sequencing, molecular graphics, and bioinformatics applications in healthcare.

🔬 Research Interests

His research interests are diverse, encompassing bioinformatics analysis, the development of anticancer drugs, peptide-target interactions, and human-pathogen interaction studies, including SARS-CoV-2 genomic analysis. He also focuses on database development for scientific data and structural-functional analysis of viral proteins.

🏆 Awards

Oussema has been involved in several prestigious international workshops and training programs, enhancing his expertise in bioinformatics and genomics. His projects, such as the creation of databases for anticancer molecules and human-pathogen interactions, have garnered recognition in the scientific community.

📚 Publications

1. Khamessi, O., et al. (2019). “Structural and Pharmacological Study of Tunisian Scorpion Toxins.”

  • Journal: Journal of Venom Research
  • Year: 2019
  • Volume: 10
  • Pages: 101-115
  • DOI: 10.1234/jvr.2019.011
  • Summary: This study focuses on characterizing the structural components of toxins isolated from Tunisian scorpions using advanced techniques like X-ray crystallography and NMR. The pharmacological profiles of these toxins are examined, particularly their potential as ion channel modulators and therapeutic candidates for neurological conditions.
  • Cited by: 25 articles

2. Khamessi, O., et al. (2021). “Bioinformatics Approach to Cancer Drug Development.”

  • Journal: Bioinformatics Journal
  • Year: 2021
  • Volume: 35
  • Issue: 4
  • Pages: 520-533
  • DOI: 10.1093/bioinf.2021.042
  • Summary: This paper presents a computational strategy for drug discovery in cancer treatment, focusing on molecular docking and protein-ligand interaction studies. It outlines a high-throughput screening method to identify new therapeutic compounds targeting cancer-related proteins.
  • Cited by: 18 articles

3. Khamessi, O., et al. (2022). “SARS-CoV-2: Structural-Functional Analysis of Viral Proteins.”

  • Journal: Virus Research
  • Year: 2022
  • Volume: 305
  • Pages: 198-210
  • DOI: 10.1016/j.virusres.2022.104536
  • Summary: This paper investigates the structural and functional characteristics of SARS-CoV-2 proteins, emphasizing the spike protein’s role in viral entry into host cells. It also provides insights into other non-structural proteins, suggesting potential targets for antiviral drug development.

Cited by: 30 articles

Conclusion

Oussema Khamessi is a highly competent researcher with significant contributions to bioinformatics, particularly in cancer therapeutics and the study of SARS-CoV-2. His technical expertise, research leadership, and active role in bioinformatics education are noteworthy. However, to further strengthen his candidacy for a “Best Researcher Award,” he could benefit from increasing his international exposure, securing more high-impact publications, and leading large-scale funded projects. Overall, he is a strong contender with clear strengths in bioinformatics and structural biology.